Global Crude Heparin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Crude Heparin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

The crude heparin is mainly extracted from the intestinal mucosa of healthy pigs. Because it contains a large amount of impurity proteins, impurity nucleic acids, microorganisms, etc., it needs to be extracted and separated by physical and chemical means. It is the main raw material of heparin APIs.

Market Overview:

The latest research study on the global Crude Heparin market finds that the global Crude Heparin market reached a value of USD 2052.56 million in 2022. It’s expected that the market will achieve USD 2771.13 million by 2028, exhibiting a CAGR of 5.13% during the forecast period.

COVID-19's Impact On Crude Oil and Refined Products

On March 9, oil prices plummeted 24%, the lowest price this year. After the failure of the OPEC transaction triggered a price war, oil prices fell to a low point. The outbreak of Covid-19 and the growing severity of overproduction of oil have caused the global crude oil market to sink into a low point.

The Covid-19 pandemic has made the demand outlook of the existing market very optimistic. The reason for the sharp drop in oil prices is the decrease in demand from the world 's major consumer countries. For example, North America, Europe, China, Japan, South Korea, South America, and now even India and Southeast. The spread of the virus will deal a heavy blow to its industry and supply chain, and affect oil demand in these areas.

Consumers may be satisfied with lower gasoline prices in a short period of time. Lower crude oil prices lower the cost of production of related basic chemicals. However, this may not be enough to offset the decline in demand for more chemical end-use products.

Market Opportunities and Drivers

The demand for downstream preparations is the main driving force for the steady development of the crude heparin industry. Heparin drugs are one of the most widely used and effective anticoagulant and antithrombotic drugs in clinical applications. Heparin drugs occupy an important position in the market of antithrombotic drugs. The increasing global aging, the growing size of the obese population and the rapid development of the emerging pharmaceutical market will drive the continued increase in the global heparin market demand. The heparin market with strong anticoagulant and antithrombotic capabilities has good development potential. The scale of heparin drugs reached US$12.58 billion in 2015, and the CAGR for 2006-2015 was about 11%. The use of developed countries such as Europe and the United States has grown steadily. Emerging markets have seen strong growth momentum due to the low drug penetration rate.

Market Challenges

Upstream raw material supply fluctuation risk

After industry competition over the past five years, a large number of small and medium-sized enterprises have withdrawn from the industry. In the future, industry competition will enter the field of refined competition, which requires major players in the industry to invest more in technology research and development, energy conservation and environmental protection investment, cost control, and marketing expansion to win more industry status for themselves.

Region Overview:

Asia Pacific had the highest growth rate of all regions.

Company Overview:

Fengrun Biological Technology Co., Ltd. is one of the major players operating in the Crude Heparin market, holding a share of 10.07% in 2020.Founded in April 2009, Fengrun Biotechnology Co., Ltd. is a large professional processing enterprise engaged in natural pork casings and crude heparin sodium. There are more than 1,000 employees, more than 300 professional technicians, more than 200 college graduates and above, with comprehensive strength. The company was listed in the National SME Stock Transfer System Co., Ltd. in April 2017.

Luohe Huisheng Bio-tech Co.,Ltd.

The company is mainly engaged in the processing and sales of pork casings (salted pork casings) and its ancillary products; extraction and sales of pharmaceutical intermediates (heparin sodium); research and development (non-development) of new products.

Segmentation Overview:

Among different product types, Pig Intestine Mucosa Heparin segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the External Sales segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Crude Heparin market covered in Chapter 3:

Hubei Wurui Bio-Engineering Co.,Ltd.
Anhui Jinxin Biology Technology Co., Ltd.
Hepac B.V.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Aspen Pharmacare Holdings Limited
Fengrun Biological Technology Co., Ltd.
Changzhou Qianhong Biopharma Co., Ltd.
Jiangsu Wanli Biotechnology Co., Ltd.
Huaian MDC Pharmaceutical Co., Ltd.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Luohe Huisheng Bio-tech Co., Ltd.

In Chapter 4 and Chapter 14.2, on the basis of types, the Crude Heparin market from 2018 to 2029 is primarily split into:

Pig Intestine Mucosa Heparin
Bovine Heparin

Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Crude Heparin market from 2018 to 2029 covers:

Internal Sales
External Sales

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)